Team
Leadership spanning discovery, manufacturing, translational research and commercialisation — with decades of experience in drug discovery, GMP manufacturing and clinical trials.
Each stage of taking a therapy to patients is led by someone who has done it before.
Drug discovery
125 NCEs & NBEs
Dr. Anita ChughGMP manufacturing & clinical trials
India’s 1st liraglutide biosimilar
Dr. Kadalmani KrishnanAnimal trials
Across multiple indications
Dr. Abhishek RajAdvancing innovation
Headed innovation centres
Dr. Sangeeta MainiCollective record of the leadership team
55
Publications
Peer-reviewed papers and book chapters across pharmacology, biochemistry and drug discovery.
Browse the record46
Patents filed
Filed across the leadership team’s careers
$7M
Grants
Research funding secured
20+
Awards
Honours and recognition
2
Books
Authored
Where our team has trained and worked
Decades of experience in drug discovery, GMP manufacturing and clinical development.
Drug discovery125 NCEs & NBEs
Co-Founder & Chief Scientific Officer
Pharmacologist with 30+ years of experience in technology development, drug discovery across large and small molecules, patenting and licensing.
GMP manufacturing & clinical trialsIndia’s 1st liraglutide biosimilar
Founder & CEO
Biochemist with over 20 years of experience in product development, GMP manufacturing, pre-clinical and clinical trials.
Scientific and strategic leaders taking our platform from the lab towards the clinic.
Vice President
Innovation and entrepreneurship leader with 16 years of experience building incubators, start-up ecosystems and technology-commercialisation programmes.
Scientist
Biochemist with 7 years of postdoctoral research in China and Israel, including animal trials across multiple indications.
Early-career researchers contributing to our laboratory and platform work.
Research Intern
Final-year medical student and software developer with expertise in prompt engineering and generative AI.
Research Intern
Biotechnologist in our Cell & Gene Therapy lab, developing γδ T cell therapy for MRD-AML, from PBMC isolation to scale-up expansion and FACS-based QC.
Peer-reviewed papers, granted and filed patents, and book chapters by our team.
We collaborate with clinicians, hospitals, academia, labs and strategic advisors. Tell us about your programme and we’ll get back to you.
